Systemic lupus erythematosus Trials in Hyderabad, India
Conditions / Systemic lupus erythematosus / Hyderabad, India
Clinical trials for Systemic lupus erythematosus investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05620407 | A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00424476 | A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) | COMPLETED | PHASE3 |
| NCT04433585 | A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) | COMPLETED | PHASE2 |
| NCT01438489 | A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus | COMPLETED | PHASE2 |
| NCT05617677 | A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00430677 | Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis | TERMINATED | PHASE2/PHASE3 |
| NCT03616964 | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) | COMPLETED | PHASE3 |
| NCT01262365 | Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus | COMPLETED | PHASE3 |
| NCT00624351 | Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease | COMPLETED | PHASE2 |
| NCT00660881 | Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease | COMPLETED | PHASE2 |